This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2008-2010.
Location History:
- Watertown, CT (US) (2008)
- Clayton, NC (US) (2009 - 2010)
Company Filing History:
Years Active: 2008-2010
Title: Katherine Bowers: Innovator in Interleukin-1 Antagonist Formulations
Introduction
Katherine Bowers is a prominent inventor based in Clayton, NC (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the development of interleukin-1 (IL-1) antagonist formulations. With a total of 3 patents to her name, her work has the potential to impact therapeutic approaches for various inflammatory conditions.
Latest Patents
Katherine's latest patents include innovative formulations of IL-1 antagonists. These formulations consist of a pre-lyophilized formulation, a reconstituted lyophilized formulation, and a stable liquid formulation. The IL-1 antagonist is preferably an IL-1 trap composed of a dimer of two fusion proteins with a specific amino acid sequence. Additionally, her formulations are designed to be stable with and without sodium chloride, utilizing phosphate or histidine buffers.
Career Highlights
Katherine Bowers is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to advance her research in biopharmaceutical formulations. Her expertise in the field has led to the development of groundbreaking therapies that address critical health issues.
Collaborations
Katherine has collaborated with notable colleagues, including Chimanlall Goolcharran and Daniel B Dix. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Katherine Bowers is a trailblazer in the development of IL-1 antagonist formulations, with a promising career marked by her innovative patents and collaborations. Her contributions to the field of biopharmaceuticals are noteworthy and continue to pave the way for future advancements.